Effect of Imipramine treatment on plasma dopamine beta-hydroxylase activity in chronic mild stress in rats

Polish Journal of Pharmacology

Volumn 56, Issue 6, 2004, Pages 825-829

  Grabowska, Mariola ^a   Schlegel Zawadzka, Małgorzata ^a   Papp, Mariusz ^b   Nowak, Gabriel ^a,b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

CMS; DBH; Imipramine; Plasma

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; IMIPRAMINE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; STRESS;

ANIMALS; ASCORBIC ACID; DEHYDROASCORBIC ACID; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; IMIPRAMINE; MALE; MOLECULAR BIOLOGY; NOREPINEPHRINE; RATS; STRESS; STRESS, PHYSIOLOGICAL;

EID: 14244269454     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cryan JF, O'Leary OF, Jin SH, Friedland JC, Quyang M, Hirsch BR, Page ME et al.: Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc Natl Acad Sci USA, 2004, 101, 8186-8191.
2. Cubells JF, Zabetian CP: Human genetics of plasma dopamine β-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacol, 2004, 174, 463-476.
3. Geffen L: Serum dopamine β-hydroxylase as an index of sympathetic function. Life Sci, 1974, 14, 1593-1604.
4. Grabowska M, Guminska M: Effect of buthobendin on dopamine β-hydroxylase in vitro. Pol J Pharmacol, 1996, 48, 39-45.
5. Grabowska M, Schlegel-Zawadzka M, Nowak G, Papp M: Using plasma dopamine beta-hydroxylase activity and its interrelations with bioelement content to predict depression in the rat model. Acta Biol Cracov, Ser Zool, 2002, 44, 41-46.
6. Hamner MB, Gold PB: Plasma dopamine beta-hydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder. Psychiatry Res, 1998, 77, 175-181.
7. Kitayama I, Yaga T, Kayahara T, Nakano K, Murase S, Otani M, Nomura J: Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex. Biol Psychiatry, 1997, 42, 687-696.
8. Landowski J, Łysiak-Szydłowska W: Low serum dopamine β-hydroxylase activity in patients with panic disorder (Polish). Psychiatr Pol, 1998, 32, 781-788.
9. Meyers BS, Alexopoulos GS, Kakuma T, Tirumalasetti F, Gabriele M, Alpert S, Bowden C et al.: Decreased dopamine β -hydroxylase activity in unipolar geriatric delusional depression. Biol Psychiatry, 1999, 45, 448-452.
10. Oyarce AM, Eipper BA: Cell-type specific storage of dopamine beta-monooxygenase. J Biol Chem, 2000, 275, 3270-3278.
11. Viveros OH: Mechanism of release of catecholamines. In: Adrenal Gland. Vol. 6. Handbook of Physiology. Ed. Blaschko H, Sayers G, Smith AD, Washington DC, American Physiological Society, 1975, 389-426.
12. Wierońska JM, Brański P, Szewczyk B, Pałucha A, Gruca P, Moryl E, Pilc A: Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in the rat hippocampus in an animal model of depression. Pol J Pharmacol, 2001, 53, 659-662.
13. Willner P: Animal models of depression: an overview. Pharmacol Ther, 1990, 45, 425-455.
14. Willner P, Muscat R, Papp M: Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev, 1992, 16, 525-534.
15. Yhou X, Espey M G, Chen JX, Hofseth LJ, Miranda KM, Hussain SP, Wink DA et al.: Inhibitory effects of nitric oxide and nitrosative stress on dopamine-beta-hydroxylase. J Biol Chem, 2000, 275, 21241-21246.
16. Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, Kim KS et al.: A quantitative-trait analysis of human plasma-dopamine-beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Gen, 2001, 68, 515-522.